PUBLISHER: The Business Research Company | PRODUCT CODE: 1720707
PUBLISHER: The Business Research Company | PRODUCT CODE: 1720707
Anaphylaxis Global Market Report 2025
Anaphylaxis is a rapid, severe allergic reaction that can be life-threatening, leading to symptoms such as difficulty breathing, swelling, and a drop in blood pressure. It requires urgent medical attention, with epinephrine being the primary treatment to reverse the effects. After the administration of epinephrine, patients are monitored in a healthcare setting to stabilize their condition and avoid complications.
The main drug classes used in the management of anaphylaxis include epinephrine, steroids, antihistamines, beta-antagonists, and others. Epinephrine is crucial in reversing severe allergic reactions by constricting blood vessels, relaxing airway muscles, and increasing heart rate. These medications are administered through different routes such as parenteral, oral, and others, and are used to treat various types of allergic reactions, including those caused by food allergies, pollen, dust mites, and more.
The anaphylaxis market research report is one of a series of new reports from The Business Research Company that provides anaphylaxis market statistics, including anaphylaxis industry global market size, regional shares, competitors with an anaphylaxis market share, detailed anaphylaxis market segments, market trends and opportunities, and any further data you may need to thrive in the anaphylaxis industry. This anaphylaxis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The anaphylaxis market size has grown strongly in recent years. It will grow from $3.24 billion in 2024 to $3.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to several factors, including the rising prevalence of food allergies, which has led to more cases of anaphylaxis. Increased awareness of anaphylaxis and its potential risks has contributed to better understanding and faster responses to allergic reactions.
The anaphylaxis market size is expected to see strong growth in the next few years. It will grow to $4.81 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to several key factors, including increasing urbanization and lifestyle changes, which are contributing to a higher incidence of anaphylaxis cases. Rising disposable incomes in emerging markets are also enabling more people to access allergy treatments and medications. Government funding for allergy research is expected to spur innovation and improve treatment options. Additionally, advancements in delivery systems for emergency treatments, such as auto-injectors, are making it easier to manage anaphylaxis more effectively. Major trends in the forecast period include a growing demand for injectable auto-injectors, integration of digital health solutions to monitor and manage anaphylaxis, a focus on making treatments more affordable, the development of preventative treatments and vaccines, and the increased use of biologics in allergy treatment.
The increasing prevalence of food allergies is expected to drive the growth of the anaphylaxis market in the coming years. Food allergies are immune system reactions triggered by certain foods, causing symptoms that can range from mild to severe, including life-threatening anaphylaxis. The rising prevalence of food allergies can be attributed to factors such as changing dietary habits, environmental influences, and improved awareness and diagnosis. Anaphylaxis treatment plays a crucial role in providing life-saving intervention for food allergy patients, rapidly reversing severe allergic reactions, alleviating symptoms such as swelling, difficulty breathing, and a drop in blood pressure, ensuring immediate stabilization, and preventing potentially fatal outcomes. It also equips patients with tools for timely action in future allergic incidents. For example, in September 2024, the World Health Organization (WHO) reported that around 220 million people worldwide are affected by food allergies. A single food product can contain multiple allergens, and individuals may be allergic to more than one type of food. Additionally, the Food Standards Agency (FSA) released a report in May 2024 revealing that over 30% of adults in the UK experienced food-related adverse reactions, and clinical assessments confirmed food allergies in approximately 6% of UK adults, which equals around 2.4 million people. Thus, the increasing prevalence of food allergies is driving growth in the anaphylaxis market.
Companies in the anaphylaxis market are focused on advancing treatments, including the development of epinephrine nasal sprays that allow for faster and more efficient drug delivery in emergencies. Epinephrine nasal sprays are medical devices that administer epinephrine (adrenaline) through the nasal passages as a treatment for severe allergic reactions, including anaphylaxis. For example, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced that Neffy (epinephrine nasal spray) received approval from the US Food and Drug Administration (FDA), making it the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray provides a non-invasive alternative to traditional epinephrine autoinjectors, offering a potentially more accessible option for emergency treatment. Neffy aims to improve patient compliance by eliminating the need for needles while providing rapid, life-saving epinephrine during severe allergic reactions.
In October 2023, Nestle Health Science SA, a Switzerland-based nutritional science company, partnered with Anaphylaxis UK to support individuals with severe allergies. This collaboration is designed to raise awareness about the serious consequences of anaphylaxis and empower individuals to manage allergies safely by providing education and resources. Anaphylaxis UK is a UK-based charity focused on severe allergies.
Major players in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy's Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abello, Stallergenes Greer, Allergy Therapeutics.
North America was the largest region in the anaphylaxis market in 2024. The regions covered in anaphylaxis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the anaphylaxis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The anaphylaxis market consists of syringes and vials, intravenous (IV) epinephrine, diagnostic kits, and monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anaphylaxis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on anaphylaxis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for anaphylaxis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anaphylaxis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Class: Epinephrine; Steroids; Antihistamines; Beta-antagonists; Other Drug Class
- 2) By Route Of Administration: Parenteral; Oral; Other Routes Of Administration
- 3) By Application: Food Allergy; Pollen Allergy; Dust Mites Allergy; Other Applications
- Subsegments:
- 1) By Epinephrine: Auto-injectors; Prefilled Syringes; Vials
- 2) By Steroids: Corticosteroids; Glucocorticoids; Mineralocorticoids
- 3) By Antihistamines: H1-receptor Antagonists; H2-receptor Antagonists
- 4) By Beta-antagonists: Selective Beta-blockers; Non-selective Beta-blockers
- 5) By Other Drug Class: Leukotriene Receptor Antagonists; Mast Cell Stabilizers
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Novartis AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Anaphylaxis Market Characteristics
3. Anaphylaxis Market Trends And Strategies
4. Anaphylaxis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Anaphylaxis Growth Analysis And Strategic Analysis Framework
- 5.1. Global Anaphylaxis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Anaphylaxis Market Growth Rate Analysis
- 5.4. Global Anaphylaxis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Anaphylaxis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Anaphylaxis Total Addressable Market (TAM)
6. Anaphylaxis Market Segmentation
- 6.1. Global Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Epinephrine
- Steroids
- Antihistamines
- Beta-antagonists
- Other Drug Class
- 6.2. Global Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Parenteral
- Oral
- Other Routes Of Administration
- 6.3. Global Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Food Allergy
- Pollen Allergy
- Dust Mites Allergy
- Other Applications
- 6.4. Global Anaphylaxis Market, Sub-Segmentation Of Epinephrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Auto-injectors
- Prefilled Syringes
- Vials
- 6.5. Global Anaphylaxis Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Corticosteroids
- Glucocorticoids
- Mineralocorticoids
- 6.6. Global Anaphylaxis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- H1-receptor Antagonists
- H2-receptor Antagonists
- 6.7. Global Anaphylaxis Market, Sub-Segmentation Of Beta-antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Selective Beta-blockers
- Non-selective Beta-blockers
- 6.8. Global Anaphylaxis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Leukotriene Receptor Antagonists
- Mast Cell Stabilizers
7. Anaphylaxis Market Regional And Country Analysis
- 7.1. Global Anaphylaxis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Anaphylaxis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Anaphylaxis Market
- 8.1. Asia-Pacific Anaphylaxis Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Anaphylaxis Market
- 9.1. China Anaphylaxis Market Overview
- 9.2. China Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Anaphylaxis Market
- 10.1. India Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Anaphylaxis Market
- 11.1. Japan Anaphylaxis Market Overview
- 11.2. Japan Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Anaphylaxis Market
- 12.1. Australia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Anaphylaxis Market
- 13.1. Indonesia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Anaphylaxis Market
- 14.1. South Korea Anaphylaxis Market Overview
- 14.2. South Korea Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Anaphylaxis Market
- 15.1. Western Europe Anaphylaxis Market Overview
- 15.2. Western Europe Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Anaphylaxis Market
- 16.1. UK Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Anaphylaxis Market
- 17.1. Germany Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Anaphylaxis Market
- 18.1. France Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Anaphylaxis Market
- 19.1. Italy Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Anaphylaxis Market
- 20.1. Spain Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Anaphylaxis Market
- 21.1. Eastern Europe Anaphylaxis Market Overview
- 21.2. Eastern Europe Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Anaphylaxis Market
- 22.1. Russia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Anaphylaxis Market
- 23.1. North America Anaphylaxis Market Overview
- 23.2. North America Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Anaphylaxis Market
- 24.1. USA Anaphylaxis Market Overview
- 24.2. USA Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Anaphylaxis Market
- 25.1. Canada Anaphylaxis Market Overview
- 25.2. Canada Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Anaphylaxis Market
- 26.1. South America Anaphylaxis Market Overview
- 26.2. South America Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Anaphylaxis Market
- 27.1. Brazil Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Anaphylaxis Market
- 28.1. Middle East Anaphylaxis Market Overview
- 28.2. Middle East Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Anaphylaxis Market
- 29.1. Africa Anaphylaxis Market Overview
- 29.2. Africa Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Anaphylaxis Market Competitive Landscape And Company Profiles
- 30.1. Anaphylaxis Market Competitive Landscape
- 30.2. Anaphylaxis Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Anaphylaxis Market Other Major And Innovative Companies
- 31.1. Sanofi SA
- 31.2. AstraZeneca plc
- 31.3. Abbott Laboratories
- 31.4. GlaxoSmithKline Plc
- 31.5. F. Hoffman-La Roche Ltd.
- 31.6. Teva Pharmaceutical Industries Ltd.
- 31.7. Bausch Health Companies Inc.
- 31.8. Perrigo Company plc
- 31.9. Dr Reddy's Laboratories Ltd.
- 31.10. Cipla Ltd.
- 31.11. Amneal Pharmaceuticals Inc.
- 31.12. Mylan N.V.
- 31.13. ALK-Abello
- 31.14. Stallergenes Greer
- 31.15. Allergy Therapeutics
32. Global Anaphylaxis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Anaphylaxis Market
34. Recent Developments In The Anaphylaxis Market
35. Anaphylaxis Market High Potential Countries, Segments and Strategies
- 35.1 Anaphylaxis Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Anaphylaxis Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Anaphylaxis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
